Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC)

Clinical trial NCT04390113 · TERMINATED

Trial details

NCT number: NCT04390113
Sponsor: AlloVir
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

BK Virus Infection Hemorrhagic Cystitis

Start date: 2021-03-18
Primary completion: 2024-01-30
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.